Free Daily Analysis

Stock Trend Analysis Report

Prepared for you on Saturday, May 25, 2024.

Range Cancer Therapeutics ETF (NASDAQ:CNCR)

Weak Downtrend (-65) - CNCR is showing signs of a strengthening downtrend. Monitor CNCR as it may be building momentum to the downside.

Is it time to buy, sell, or avoid CNCR?

MarketClub looks at technical strength and momentum to determine if the timing is right for CNCR.

Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.

Open High Low CNCR Price Change
14.67 14.72 14.51 14.53 -0.06
Entry Signal

MarketClub’s Trade Triangles for CNCR

long term up The long-term trend has been UP since Dec 14th, 2023 at 12.27

intermediate term down The intermediate-term trend has been DOWN since Mar 18th, 2024 at 15.85

short term down The short-term trend has been DOWN since May 23rd, 2024 at 14.82

Smart Scan Analysis for CNCR

Based on our trend formula, CNCR is rated as a -70 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).

Smart Scan Analysis for CNCR
Strong Downtrend Sideways Strong Uptrend
Open High Low Price Change
14.67 14.72 14.51 14.53 -0.06
Prev. Close Volume Bid Ask Time
14.61 1889 2024-05-24 15:59:52
Year High32.32Year High Date2018-03-13
Year Low19.1252Year Low Date2018-10-29
52wk High17.959952wk High Date2024-03-01
52wk Low9.2252wk Low Date2023-10-27
Average Volume10,312Shares Outstanding100
Market Cap34MVolatility39.81
Get a free daily analysis and signals for Range Cancer Therapeutics ETF (CNCR) - Request Your Free Report.